中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 3-methoxy-5,8,9,13b-tetrahydro-6H-isoquino[1,2-a]isoquinoline | 62310-92-3 | C18H19NO | 265.355 |
Dibenzo- and benzindolo-azecines represent a class of potential neuroleptics. To characterize the effectiveness at the dopamine and 5-HT2A-receptor representative structures were synthesized and tested by radio ligand binding studies, in vivo and in vitro studies.
Neuroleptic potency and the risk of side effects of the prodrug 7-methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecin-3-yl isobutyrate, an ester derivative of the most promising azecine 7-methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecin-3-ol (LE404), was tested in vivo concerning conditioned avoidance response inhibition, locomotor activity and triggering of catalepsy vs. haloperidol as a reference. Also ester hydrolysis was examined using porcine liver esterase to thereby obtain an indication of the stability of the prodrug in vivo. An HPLC method was developed for purity control and determination of octanol/water-distribution coefficients.
It has been shown that the tested substances in their efficacy are comparable to haloperidol and risperidone, but the therapeutic index in most cases is larger. Esterification as a prodrug principle leads to significantly prolonged effectiveness.
二苯并[b]氮杂环和苯并[b]氮杂环是一类潜在的神经类药物。为了表征它们在多巴胺和5-HT2A受体上的效力,代表性结构被合成并通过放射性配体结合研究,体内和体外研究进行了测试。
通过对比参考药物氟哌啶,采用体内条件性避免反应抑制、运动活动和触发白鼠强直的方法,测试了前药7-甲基-5,6,7,8,9,14-六氢二苯并[d,g]氮杂环-3-酸异丁酯的神经类药效和副作用风险。同时,使用猪肝酯酶检测酯水解,从而获得前药在体内的稳定性指示。还开发了高效液相色谱法进行纯度控制和辛醇/水分配系数的测定。
研究表明,测试的物质在其功效上与氟哌啶和利培酮相当,但在大多数情况下,治疗指数更大。酯化作为一种前药原理,可以显著延长其有效性。